Kapil Saxena, MD
Volunteer Assistant Clinical Professor
Medicine
School of Medicine

Education & Training

Show all (4) Hide

• Fellowship Hematology/Oncology MD Anderson Cancer Center 2022
• Residency Internal Medicine University of California, San Francisco 2019
• M.D. Baylor College of Medicine 2016
• B.A. University of Texas at Austin 2011

Publications (14)

Top publication keywords:
Blast CrisisVirus ReplicationGastric BypassCopperLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRotavirus InfectionsBone Marrow ExaminationInterferonsLeukemia, Myeloid, AcuteRotavirusAzacitidineAntineoplastic AgentsPancytopeniaOrgan Culture TechniquesIntestine, Small

• BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic Mechanism.
  Research square 2024 Yee C, Saxena K, Ryu E, Hung SH, Singh S, Zhang Q, Zeng Z, Wang Z, Konopleva M
• Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses.
  Nature cancer 2024 DiNardo CD, Verma D, Baran N, Bhagat TD, Skwarska A, Lodi A, Saxena K, Cai T, Su X, Guerra VA, Poigaialwar G, Kuruvilla VM, Konoplev S, Gordon-Mitchell S, Pradhan K, Aluri S, Hackman GL, Chaudhry S, …
• A Short-Lived Crisis.
  Journal of hospital medicine 2021 Saxena K, Dhaliwal G, Rao MN, Babik JM
• SOHO State of the Art Updates and Next Questions:Harnessing Apoptosis in AML.
  Clinical lymphoma, myeloma & leukemia 2021 Saxena K, DiNardo C, Daver N, Konopleva M
• A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia.
  Cancer 2021 Saxena K, Herbrich SM, Pemmaraju N, Kadia TM, DiNardo CD, Borthakur G, Pierce SA, Jabbour E, Wang SA, Bueso-Ramos C, Loghavi S, Tang G, Cheung CM, Alexander L, Kornblau S, Andreeff M, Garcia-Manero G,…

Show all (9 more) Hide

• Impact of frontline treatment approach on outcomes of myeloid blast phase CML.
  Journal of hematology & oncology 2021 Saxena K, Jabbour E, Issa G, Sasaki K, Ravandi F, Maiti A, Daver N, Kadia T, DiNardo CD, Konopleva M, Cortes JE, Yilmaz M, Chien K, Pierce S, Kantarjian H, Short NJ
• New Treatment Options for Older Patients with Acute Myeloid Leukemia.
  Current treatment options in oncology 2021 Saxena K, Konopleva M
• Harnessing Apoptosis in AML.
  Clinical lymphoma, myeloma & leukemia 2020 Saxena K, DiNardo C, Daver N, Konopleva M
• An expert overview of emerging therapies for acute myeloid leukemia: novel small molecules targeting apoptosis, p53, transcriptional regulation and metabolism.
  Expert opinion on investigational drugs 2020 Saxena K, Konopleva M
• A 54-Year-Old Man With Pancytopenia.
  JAMA 2019 Saxena K, Vu K, Nye HE
• Human Intestinal Enteroids: New Models to Study Gastrointestinal Virus Infections.
  Methods in molecular biology (Clifton, N.J.) 2019 Zou WY, Blutt SE, Crawford SE, Ettayebi K, Zeng XL, Saxena K, Ramani S, Karandikar UC, Zachos NC, Estes MK
• A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection.
  Proceedings of the National Academy of Sciences of the United States of America 2017 Saxena K, Simon LM, Zeng XL, Blutt SE, Crawford SE, Sastri NP, Karandikar UC, Ajami NJ, Zachos NC, Kovbasnjuk O, Donowitz M, Conner ME, Shaw CA, Estes MK
• Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology.
  Journal of virology 2015 Saxena K, Blutt SE, Ettayebi K, Zeng XL, Broughman JR, Crawford SE, Karandikar UC, Sastri NP, Conner ME, Opekun AR, Graham DY, Qureshi W, Sherman V, Foulke-Abel J, In J, Kovbasnjuk O, Zachos NC, …
• Severe cutaneous human papillomavirus infection associated with natural killer cell deficiency following stem cell transplantation for severe combined immunodeficiency.
  The Journal of allergy and clinical immunology 2014 Kamili QUA, Seeborg FO, Saxena K, Nicholas SK, Banerjee PP, Angelo LS, Mace EM, Forbes LR, Martinez C, Wright TS, Orange JS, Hanson IC